CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one","$":{"href":"/biotech/takeda-scraps-another-phase-2-stage-celiac-disease-therapy-one-hope-left","hreflang":"en"}}]}

Phase 2negativeNegative
AI Analysis

Summary

Takeda has discontinued another phase 2 celiac disease therapy, leaving the company with only one remaining candidate in this therapeutic area.

Clinical Trial Data

Phase

2

Primary Endpoint

Not Met

Outcome Details

Phase 2 celiac disease therapy discontinued

Importance:5/10
Sentiment:
-0.70
pipeline_reductiondrug_discontinuationceliac_diseasephase_2
Related Companies

Read the original article

Published by FierceBiotech on July 30, 2026 7:28 AM

Read Original